Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Michael Morgan, MD, PhD

Michael Morgan, MD, PhD

  • Assistant Professor, CWRU School of Medicine
  • Specialty: Neurology-NeuroOphthalmology
  • Location:
    UH Cleveland Medical Center Bolwell
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Michael Morgan, MD, PhD

Expertise

  • Neuro-Ophthalmology

Certifications & Memberships

  • Neurology - American Board of Psychiatry and Neurology

Education

Fellowship | Neuro-Ophthalmology
Neuro-Ophthalmology - Methodist Hospital (Houston) (2013 - 2015)

Residency | Neurology
Neurology - Barnes-Jewish Hospital (2009 - 2013)

Medical Education
Washington University School Of Medicine In St Louis (2009)

Undergraduate
University Of Mississippi (2000)

Undergraduate
Rice University (1997)

About

Michael L. Morgan, MD joined the University Hospitals Eye Institute in 2015 and serves as the director of clinical neuro-ophthalmology with an additional appointment in the Department of Neurology. Dr. Morgan is fellowship-training in neuro-ophthalmology with certification in neurology by the American Board of Psychiatry and Neurology. He received his MD & PhD degrees with graduate research in neuroscience on vision motion processing in 2013 at Washington University in St. Louis. He then completed a neurology residency at Washington University in St. Louis / Barnes-Jewish Hospital, followed by a fellowship in neuro-ophthalmology. 

Dr. Morgan's clinical interests encompass aspects of neuro-ophthalmology involving afferent (incoming) neural aspects of vision and movements and alignment of the eyes. He treats patients with idiopathic intracranial hypertension (pseudotumor cerebri), optic neuritis, non-arteritic anterior ischemic optic neuropathy, giant cell arteritis / arteritic anterior ischemic optic neuropathy, and diplopia, including ocular myasthenia gravis and thyroid eye disease, and visual problems resulting from strokes and brain tumors. He works closely with colleagues within the Department of Ophthalmology, the Department of Neurology, and the Department of Neurosurgery at University Hospitals.

Dr. Morgan teaches medical students and residents in both ophthalmology and neurology. At the Case Western Reserve University School of Medicine, he teaches fundamentals of the visual pathways to students in their pre-clinical years. Dr. Morgan enjoys having interested students join him again in their clinical years. Within the UH Eye Institute, he teaches every resident in an intensive two-month rotation on neuro-ophthalmology. He was named Attending of the Year for 2018-2019 to honor his unrelenting commitment to resident education. He leads an organization of Grand Rounds and serves on the accreditation committee for the ophthalmology residency. He also lectures residents in the Department of Neurology and leads the monthly joint Neuro-Ophthalmology Conference involving both the ophthalmology and neurology departments. He is active in the Cleveland Ophthalmological Society to update area ophthalmologists on neuro-ophthalmology. As a North American Neuro-Ophthalmology Society member, he serves on the Continuing Medical Education Committee and Patient Information Committee to educate both other doctors and patients on neuro-ophthalmological diseases. He is also a member of the American Academy of Neurology.

Research & Publications

Research Interests

Neuro-Ophthalmology

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Michael Morgan did not disclose any Outside Relationships with Industry.